375 results on '"therapy"'
Search Results
2. Effect of Capsaicin Atomization-Induced Cough on Sputum Excretion in Tracheotomized Patients after Hemorrhagic Stroke: A Randomized Controlled Trial
- Author
-
Wu, Chao, Zhang, Yijie, Yang, Li, Shen, Fang, Ma, Chen, and Shen, Meifen
- Abstract
Background: Timely and effective removal of respiratory secretions is of great significance for tracheotomized patients. The purpose of this study is to investigate the effectiveness of capsaicin nebulization to stimulate cough to promote early clearance of respiratory secretions in tracheotomized patients after hemorrhagic stroke. Method: This study implemented a randomized controlled design. Sixty-three patients who were tracheotomized following a hemorrhagic stroke completed this randomized controlled trial. In the control group, 33 cases were given a routine care after tracheotomy. In the intervention group, 30 cases were given a capsaicin solution nebulization in addition to the routine care. The daily sputum output and the number of sputum suctioning were observed. The differences in sputum viscosity, cough function, and Clinical Pulmonary Infection Score (CPIS) were compared between the two groups before and after the intervention. Vital sign changes during capsaicin nebulization and suctioning were compared between the two groups in a pilot study. Results: The daily sputum output of the capsaicin intervention group was significantly higher than that of the control group (p < 0.05). The number of sputum suctioning of capsaicin group was less than that of the control group after intervention (p < 0.05). The CPIS score of the capsaicin group was lower than that of the control group (p < 0.05) after a 1-week intervention. Patients' heart rate, respiratory rate, and oxygen saturation during capsaicin nebulization were not statistically different from those during routine sputum suctioning (p > 0.05). Conclusions: Capsaicin atomization-induced cough can effectively promote sputum excretion of hemorrhagic stroke patients undergoing tracheotomy and has a good safety profile. The Clinical Trial registration number of this study is ChiCTR2000037772 (http://www.chictr.org.cns).
- Published
- 2021
- Full Text
- View/download PDF
3. Psychometric Properties of the Chinese Version of the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM)
- Author
-
Zhang, Ya, Hu, Jing, Evans, Chris, Jin, Li Wei, Wu, Meng Yang, Wang, Chun Yin, Zhang, Xiao Jin, Lu, Wei Hong, and Chen, Guo Peng
- Abstract
To develop the Chinese version of Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) and examine its psychometric properties, we investigated a sample of 689 non-clinical and 309 clinical participants and found this measurement had good acceptability, internal reliability, test-retest reliability and convergent validity; it had moderate correlations with the Schwartz Outcome Scale and Symptom Check List-90, which showed an acceptable concurrent validity. Specifically, we explored the cut-off line of clinical criterion and found a g factor plus three-factor solution better than original four-domain model in Chinese context. The CORE-OM is a valid tool with referenced cut-offs to measure clinical outcomes, which can bridge the gap in routine clinical evaluation in China.
- Published
- 2020
- Full Text
- View/download PDF
4. Evaluation of an Online 'Internationalization at Home' Course on the Social Contexts of Addiction
- Author
-
Lee, Bonnie K. and Cai, Huixiang
- Abstract
Internationalization of higher education to include international, intercultural, or global components into the delivery of postsecondary education has drawn increasing attention in the last two decades. A globally relevant course focusing on the "Social Contexts of Addiction" engaged students' online interaction at a Canadian university with learners from across various institutions in mainland China, Macau, and Hong Kong. Although "internationalization at home" (IaH) is one of the most prevalent themes in the internationalization literature, empirical evaluation of its merits along with the challenges of its implementation is still limited. In this article, the authors used student and faculty feedback to identify the design factors of this online IaH course that facilitated its success and transformative benefits. Discussion highlighted several follow-up strategic initiatives to broaden the adoption and conversations on internationalization in teaching, and the necessity of multilevel support and alignments among government, university, and faculty leadership to sustain internationalization efforts across the curriculum.
- Published
- 2019
- Full Text
- View/download PDF
5. Exploring How Chinese Primary School Psychological Counsellors Understand and Use Therapeutic Stories
- Author
-
Liu, Xi and Williams, Antony
- Abstract
Psychological counsellors in western countries have used stories and storytelling for therapeutic purposes for decades. However, the development of the profession of school counselling in China is at an early stage and little research has been done on using therapeutic stories in Chinese primary school settings. This exploratory study presents qualitative data on using therapeutic stories collected from interviews with Chinese psychological counsellors who work with primary school students. Findings from a grounded theory analysis revealed that therapeutic stories were used by the participants in various therapeutic approaches. A spectrum of therapist directiveness was developed to integrate different ways of using therapeutic stories.
- Published
- 2019
- Full Text
- View/download PDF
6. Addressing Autism Spectrum Disorders in China
- Author
-
Wang, Bo, Cao, Futao, and Boyland, Joyce Tang
- Abstract
English language readers rarely get glimpses of the state of autism research in China. Given the seriousness of autism, the population of China, and the potential for theoretically interesting cross-cultural insights, we provide a broad survey of research carried out in China on childhood autism. Four themes are considered: etiology, diagnosis, treatment, and education. Autism spectrum disorders (ASD) appears to be a product of epigenetic interactions between genetic and environmental factors; recent Chinese research on etiology reflects this. Current diagnostic procedures in China involve clinical screening and examinations, while research proceeds on brain-imaging techniques for diagnosis. Research on treatment has introduced a comprehensive and moderately effective approach that includes education and training, psychotherapy, and pharmacotherapy. In the realm of education, however, many problems remain, requiring joint efforts of the government and of other societal actors. Finally, there are opportunities for indigenous Chinese concepts and innovations to contribute to the study of ASD.
- Published
- 2019
- Full Text
- View/download PDF
7. Counseling Chinese Patients about Cigarette Smoking: The Role of Nurses
- Author
-
Li, Han Zao, Zhang, Yu, MacDonell, Karen, Li, Xiao Ping, and Chen, Xinguang
- Abstract
Purpose: The main purpose of this study is to determine the cigarette smoking rate and smoking cessation counseling frequency in a sample of Chinese nurses. Design/methodology/approach: At the time of data collection, the hospital had 260 nurses, 255 females and five males. The 200 nurses working on the two daytime shifts were given the questionnaires; none refused to participate, reaching a response rate of 100 percent. All the participants were females as the five male nurses were working in the operation rooms at the time of data collection, are were thus not accessible. Findings: Some key findings include: only two nurses, out of 200, identified themselves as current cigarette smokers; all provided anti-smoking counseling to patients, the majority of them did not think their efforts were successful; cigarette smoking is a problem in China: the nurses estimated that 80 percent of male and 10 percent of female patients were current smokers; in the opinions of the nurses, Chinese smokers used smoking as a stress reliever and a social lubricant; two methods may help smokers to quit or reduce smoking: using aids such as patches, acupuncture and nicotine gum, and counseling by health professionals; the nurses think that cigarette smoking is well accepted in the Chinese culture. Practical implications: Findings of this research suggest that the Chinese Ministry of Health should take measures to change the cultural norms and values regarding cigarette smoking including strict rules be imposed on not passing/sharing cigarettes in the workplace. Originality/value: In a collectivistic culture such as China where opinions of authorities are respected, the part of nurses, who represent health authority to their patients, in assisting patients to quit or reduce smoking cannot be overemphasized. This study adds to the scarce research on Chinese nurses' role in helping patients' smoking cessation efforts. (Contains 5 tables.)
- Published
- 2012
- Full Text
- View/download PDF
8. Cultural Bridging through Shared Adventure: Cross-Cultural Perspectives on Adventure Therapy
- Author
-
Norton, Christine L. and Hsieh, Chi-Mou
- Abstract
This paper examines the importance of the therapeutic relationship and the need for cultural competence in adventure therapy. Cultural differences between therapist and client can sometimes result in possible misinterpretation and conflict, which can lead to problems in the therapeutic relationship and negatively affect treatment outcomes. This paper builds on current research in adventure education and therapy examining the therapeutic relationship, cultural competence and multicultural factors, and emphasizes the need for "cultural bridging through shared adventure." A framework is presented for using shared adventure to develop the therapeutic relationship cross-culturally in adventure therapy. An example of a Taiwanese adventure therapy initiative is presented highlighting the use of shared adventure to create a cultural bridge following a natural disaster in the Szechuan province of China.
- Published
- 2011
- Full Text
- View/download PDF
9. Collectivistic Conflict of Chinese in Counseling: Conceptualization and Therapeutic Directions
- Author
-
Kwan, Kwong-Liem Karl
- Abstract
Rapid Westernization and modernization in most Chinese societies has triggered a process of acculturation to Western value orientations, which induced conflicts between Confucian-based collectivism and Western individualism at both the societal and individual levels. A review of research instruments indicated that a cultural conflict approach is often used when assessing the personality and psychological functioning of Chinese people within and outside the United States. In spite of the receptiveness toward Western influences, family and collectivistic orientation are Confucian virtues and remain dominant values that govern the interpersonal and normative relationships in Chinese societies. Within this cultural conflict context, the concept of collectivistic conflict is proposed to conceptualize the psychological adaptation and counseling concerns of the Chinese. The development of a compromising self and the reintegration of the indigenous coping mechanism of self-cultivation (i.e., striving to be a cultivated, cultured person) are postulated as therapeutic tasks when helping Chinese clients resolve collectivistic conflict. (Contains 1 table.)
- Published
- 2009
- Full Text
- View/download PDF
10. Validation of a Tibetan Translation of the Hopkins Symptom Checklist-25 and the Harvard Trauma Questionnaire
- Author
-
Lhewa, Dechen, Banu, Sophia, Rosenfeld, Barry, and Keller, Allen
- Abstract
This study sought to translate and validate the Hopkins Symptom Checklist-25 (HSCL) and the Harvard Trauma Questionnaire (HTQ) in a Tibetan population. Translated questionnaires were administered to 57 Tibetan survivors of torture/human rights abuses living in the United States and receiving services in a torture treatment program. Participants were evaluated to determine if they met criteria for major depressive episode, generalized anxiety disorder, or posttraumatic stress disorder (PTSD). Coefficient alpha for the HSCL Anxiety subscale (0.89), Depression subscale (0.92), and the HTQ (0.89) were high. Diagnostic accuracy using receiver operating characteristic curve analysis generated good classification accuracy for anxiety (0.89), depression (0.92), and PTSD (0.83). However, although sensitivity and specificity for HSCL subscales were quite high, the HTQ generated low sensitivity (0.33), partly because of a low rate of PTSD. Results support the reliability and validity of the HSCL but suggest further study of the HTQ with this population is required. (Contains 4 tables.)
- Published
- 2007
- Full Text
- View/download PDF
11. Culture and Continuing Bonds: A Prospective Comparison of Bereavement in the United States and the People's Republic of China
- Author
-
Lalande, Kathleen M. and Bonanno, George A.
- Abstract
There has been an increased interest and debate regarding the adaptiveness of continuing bonds with the deceased. The authors used data from a cross-cultural study of 61 participants from the United States (US) and 58 participants from the People's Republic of China (PRC) who completed measures of continuing bonds and adjustment at 4 and 18 months of bereavement. Higher levels of continuing bonds in the PRC at 4 months were related to better adjustment at 18 months. In contrast, results in the US showed that higher levels of continuing bonds were related to poorer adjustment at 18 months. The data suggest that culture should be addressed in the development of effective grief therapies, especially when considering continuing bonds with the deceased.
- Published
- 2006
12. Perceived Treatment Effectiveness of Family Therapy for Chinese Patients Suffering from Anorexia Nervosa: A Qualitative Inquiry
- Author
-
Ma, Joyce L. C. and Lai, Kelly
- Abstract
Although family therapy has become highly acceptable in the West, its applicability and acceptability for Chinese adolescents and young women with anorexia nervosa (AN) remains unknown. In this article, we report the results of a qualitative study using post-treatment in-depth interviews to understand the subjective perceptions of sufferers of AN as well as their families towards family therapy. The majority of the recovered patients (n = 24) perceived the helpfulness of family therapy in resolving their problem of self-starvation. Only two respondents thought otherwise. Family therapy was perceived to be helpful in lowering the psychological distress of the parents, reducing family conflicts, and increasing family cohesion. The results underscore the importance of the therapist in being flexible and versatile in treatment.
- Published
- 2006
- Full Text
- View/download PDF
13. Batroxobin can improve the efficacy of combination therapy for profound sudden sensorineural hearing loss greater than but not less than 100 dB HL.
- Author
-
Jiang, Li Zhu and Zuo, Wen Qi
- Subjects
- *
VENOM , *DRUG efficacy , *METHYLPREDNISOLONE , *LIDOCAINE , *KRUSKAL-Wallis Test , *STATISTICS , *COMBINATION drug therapy , *HEARING levels , *INTRAVENOUS therapy , *CONVALESCENCE , *ORAL drug administration , *PROTEOLYTIC enzymes , *SENSORINEURAL hearing loss , *RETROSPECTIVE studies , *CASE-control method , *GINKGO , *MANN Whitney U Test , *COMPARATIVE studies , *AUDIOMETRY , *DESCRIPTIVE statistics , *FIBRINOGEN , *CHI-squared test , *RESEARCH funding , *PLANT extracts , *PREDNISONE , *DATA analysis software , *DATA analysis - Abstract
Objective: To investigate the effects of combination therapy with and without batroxobin, and the frequency of batroxobin use on the prognosis of profound sudden sensorineural hearing loss. Methods: Hearing recovery in the batroxobin group (231 patients) and non-batroxobin group (56 patients) was compared. The correlation between the number of times batroxobin was used and hearing recovery was analysed. Results: The decrease in hearing threshold and overall improvement rate in the batroxobin group with hearing loss exceeding 100 dB HL was significantly higher than that in the non-batroxobin group. There was no linear correlation between the number of times batroxobin was used and the overall improvement rate. Using batroxobin two to three times achieved a therapeutic effectiveness plateau. Conclusion: Batroxobin can improve the efficacy of combination therapy for profound sudden sensorineural hearing loss exceeding 100 dB HL, and using batroxobin two to three times yields the maximum overall improvement rate. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. The I Ching as a Potential Jungian Application: History and Practice.
- Author
-
Zeng, Jingchao
- Subjects
- *
JUNGIAN psychology , *PATIENT-professional relations , *DIVINATION , *MATURATION (Psychology) , *INTERPERSONAL relations , *PSYCHIATRISTS - Abstract
Swiss psychiatrist Carl Jung had a lifelong interest in the I Ching after discovering it in 1919. Jung's interest in the I Ching is arguably more practical than purely theoretical or intellectual, and references to I Ching divination appear frequently in his various publications, seminars, letters and clinical practice records. After a few observations on the history of the study of the I Ching in China, the author categorizes Jung's three uses of the I Ching as physical use (to preview future potentials of outer reality), psychological use (to reveal one's psychological state), and psychical approach (to engage with the divine through "神"["shen", spiritual agencies]). Finally, the author discusses the current Jungian engagement by demonstrating clinical cases in contemporary times. Some Jungian analysts practise I Ching divination to obtain insights into the physical and psychological state of therapeutic relationships and for personal development. This paper is a historical and critical engagement of the Jungian practice of I Ching divination. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis.
- Author
-
Bo Song, Zheyu Lin, Chuyao Feng, Xu Zhao, and Weiping Teng
- Subjects
BIBLIOMETRICS ,THYROID cancer ,CANCER treatment ,IODINE isotopes ,MEDICAL technology ,WATCHFUL waiting - Abstract
Background: Papillary thyroid cancer (PTC) is the most common endocrine malignancy worldwide. The treatment of PTC has attracted extensive attention and discussion from the public and scholars. However, no article has systematically assessed the related literature. Therefore, we conducted a bibliometric and knowledge map analysis to reveal the dynamic scientific developments in the PTC therapy field. Methods: We retrieved publications related to PTC therapy from the Web of Scientific Core Collection (WoSCC) on May 1, 2023. The bibliometric package in R software, VOSviewer and CiteSpace software were used to analyze countries/ regions, institutions, journals, authors, references, and keywords. Then, we systematized and summarized the research landscape, global trends and hot topics of research. Results: This bibliometric analysis spanned from 2012 to 2022 and involved 18,501 authors affiliated with 3,426 institutions across 87 countries/regions, resulting in the publication of 3,954 papers in 860 academic journals. Notably, the number of publications and citations related to PTC therapy research has exhibited a steady increase over the past decade. China and the United States have emerged as leading contributors in terms of publication count, with the United States also being the most cited country. Furthermore, among the top 10 institutions with the highest number of published papers, half were located in China. Among the journals, Thyroid is ranked first in terms of total publications and citations. The most productive individual author was Miyauchi Akira. While previous research primarily focused on surgery and radioactive iodine therapy, the increasing emphasis on health awareness and advancements in medical technology have led to the emergence of active surveillance, thermal ablation, and genomic analysis as prominent areas of research. Conclusion: In conclusion, this comprehensive and quantitative bibliometric analysis elucidates the research trends and hotspots within PTC therapy, drawing rom a substantial body of publications. This study provides valuable insights into the historical and current landscape of PTC therapy research while also offering guidance for future research directions. This study serves as a valuable resource for researchers and practitioners seeking new avenues of exploration in the field. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Traditional Chinese Medicine for Breast Cancer: A Review.
- Author
-
Feng, Rui-Qi, Li, De-Hui, Liu, Xu-Kuo, Zhao, Xiao-Hui, Wen, Qian-Er, and Yang, Ying
- Subjects
CHINESE medicine ,CHEMOTHERAPY complications ,BREAST cancer ,CHINESE people ,CANCER treatment - Abstract
A total of 18% of global breast cancer (BC) deaths are attributed to BC in China, making it one of the five most common cancers there. There has been a steady rise in BC morbidity and mortality in women in the last few years and it is now a leading cancer among Chinese women. Conventional treatments for BC are currently effective but have several limitations and disadvantages, and Traditional Chinese medicine (TCM) plays a vital role in the overall process of cancer prevention and therapy. It is known that TCM can treat a variety of conditions at a variety of sites and targets. In recent years, increasingly, research has been conducted on TCM's ability to treat BC. TCM has shown positive results in the treatment of breast cancer and the adverse effects of radiotherapy and chemotherapy. This review describes the progress of clinical observation and mechanism research of TCM in the treatment of breast cancer in recent years. It provides some ideas and theoretical basis for the treatment of BC with TCM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China.
- Author
-
Wang, Meng, Liu, Caiyun, Zou, Meijuan, Niu, Zixuan, Zhu, Jie, and Jin, Tao
- Subjects
EPIDEMIOLOGY ,MULTIPLE sclerosis ,NEURODEGENERATION ,INFLAMMATION - Abstract
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system characterized by inflammation, demyelination, and neurodegeneration. It mainly affects young adults, imposing a heavy burden on families and society. The epidemiology, clinical features, and management of MS are distinct among different countries. Although MS is a rare disease in China, there are 1.4 billion people in China, so the total number of MS patients is not small. Because of the lack of specific diagnostic biomarkers for MS, there is a high misdiagnosis rate in China, as in other regions. Due to different genetic backgrounds, the clinical manifestations of MS in Chinese are different from those in the West. Herein, this review aims to summarize the disease comprehensively, including clinical profile and the status of disease-modifying therapies in China based on published population-based observation and cohort studies, and also to compare with data from other countries and regions, thus providing help to develop diagnostic guideline and the novel therapeutic drugs. Meanwhile, we also discuss the problems and challenges we face, specifically for the diagnosis and treatment of MS in the middle- and low-income countries. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. The therapeutic effect of extracorporeal shock wave therapy combined with Kinesio Tape on plantar fasciitis.
- Author
-
Zhao, Jing and Jiang, Yunfei
- Subjects
- *
PAIN measurement , *TAPING & strapping , *VISUAL analog scale , *TREATMENT effectiveness , *FUNCTIONAL assessment , *RANDOMIZED controlled trials , *PLANTAR fasciitis , *FOOT , *RESEARCH funding , *DESCRIPTIVE statistics , *ULTRASONIC therapy , *COMBINED modality therapy , *STATISTICAL sampling , *EVALUATION - Abstract
BACKGROUND: Extracorporeal shock wave therapy (ESWT) combined with Kinesio Tape (KT) for plantar fasciitis (PF) is lacking in the literature. OBJECTIVE: This study aimed to investigate the effect of ESWT combined with KT on foot pain and function in patients with PF based on ultrashort wave therapy and stretching. METHODS: A total of 91 patients with PF were randomly divided into the ESWT group (ETG, n = 23), KT group (KTG, n = 23), combined treatment group (CTG, n = 22) and control group (CG, n = 23). Herein, changes in visual analysis scale (VAS) score, plantar fascia thickness (PFT) and American Orthopaedic Foot and Ankle Society (AOFAS) score were examined. RESULTS: The groups were compared after 4 weeks and the results showed that the VAS scores of ETG, KTG and CTG were significantly smaller than that of CG (P < 0.05). In addition, the VAS score of CTG was significantly smaller than that of KTG (P < 0.001). Meanwhile, the AOFAS scores of ETG and CTG were significantly greater than that of CG (P < 0.001). Moreover, the AOFAS score of CTG was significantly greater than those of ETG and KTG (P < 0.01). Comparisons within groups were also conducted at weeks 0 and 4 and the results showed that the VAS scores of ETG, KTG and CTG significantly decreased (P < 0.001); the PFT of ETG and CTG significantly decreased (P < 0.05); and the AOFAS score of ETG, KTG and CTG significantly increased (P < 0.001). CONCLUSION: Based on ultrashort wave therapy and stretching, ESWT and KT therapy could improve the foot pain and function of patients with PF, and the combined modality therapy is more effective. ESWT and combined treatment has a positive effect on patients' PFT. However, single KT treatment has a limited effect on PFT. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Efficacy of interpersonal psychotherapy in mainland China: a systematic review and meta-analysis.
- Author
-
Luhan Tang, Fangzhong Xu, Ge Yu, Chong Li, Sijin Wen, and Wanhong Zheng
- Subjects
INTERPERSONAL psychotherapy ,POSTPARTUM depression ,MENTAL depression ,CHINESE-speaking students ,SOCIAL anxiety - Abstract
Objective: Interpersonal Psychotherapy (IPT) is an evidence-based therapy. There have been increasing demand and training opportunities of IPT in China. Reviewing current evidence on its use in Chinese patients can help us understand the applicability of IPT in China and identify knowledge gaps to encourage and better future research in this field. Method: We did a comprehensive search of three major electronic databases: PubMed (English), Chinese National Knowledge Infrastructure (CNKI) and WanFang Data (Chinese). We examined overall study design, outcome measures, data analyses and other parameters. We only selected articles of Randomized Clinical Trials (RCT) for this review. All study findings were grouped and summarized per psychiatric diagnoses. The meta-analysis and forest plots were performed whereas studies could be combined. Results: After a full text review of 132 articles, 40 were selected for the final review. Comparing with control groups, evidences supported the efficacy of IPT in Chinese patients with Major Depressive Disorder (MDD), Postpartum depression, Generalized Anxiety Disorder (GAD), Social Anxiety Disorder, Post Stress Traumatic Disorder (PTSD), and Post-psychotic Depression. It was also beneficial to college students and Chinese first-time mothers. Meta-analysis using a random-effects model consistently yielded significant score differences between the IPT and control groups (p < 0.0001) on MDD. Conclusion: This systematic review has identified the current best evidence for IPT efficacy in Chinese population. The findings support IPT as an effective treatment in Chinese with certain psychiatric conditions, consistent with those from many other studies throughout the world. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Thalidomide as an Effective Treatment in Sideroblastic Anemia, Immunodeficiency, Periodic Fevers, and Developmental Delay (SIFD).
- Author
-
Li, Yan, Deng, Mengyue, Han, Tongxin, Mo, Wenxiu, and Mao, Huawei
- Subjects
- *
ANEMIA treatment , *DEVELOPMENTAL delay , *THALIDOMIDE , *FEVER , *SYMPTOMS , *LYMPHOPENIA - Abstract
Purpose: Sideroblastic anemia, immunodeficiency, periodic fevers, and developmental delay (SIFD) is an autosomal recessive syndrome caused by biallelic loss-of-function variant of tRNA nucleotidyl transferase 1 (TRNT1). Efficacious methods to treat SIFD are lacking. We identified two novel mutations in TRNT1 and an efficacious and novel therapy for SIFD. Methods: We retrospectively summarized the clinical records of two patients with SIFD from different families and reviewed all published cases of SIFD. Results: Both patients had periodic fever, developmental delay, rash, microcytic anemia, and B cell lymphopenia with infections. Whole-exome sequencing of patient 1 identified a previously unreported homozygous mutation of TRNT1 (c.706G > A/p.Glu236Lys). He received intravenous immunoglobulin (IVIG) replacement and antibiotics, but died at 1 year of age. Gene testing in patient 2 revealed compound heterozygous mutations (c.907C > G/p.Gln303Glu and c.88A > G/p.Met30Val) in TRNT1, the former of which is a novel mutation. Periodic fever was controlled in the first month after adalimumab therapy and IVIG replacement, but recurred in the second month. Adalimumab was discontinued and replaced with thalidomide, which controlled the periodic fever and normalized inflammatory markers effectively. A retrospective analysis of reported cases revealed 69 patients with SIFD carrying 46 mutations. The male: female ratio was 1: 1, and the mean age of onset was 3.0 months. The most common clinical manifestations in patients with SIFD were microcytic anemia (82.6%), hypogammaglobulinemia/B cell lymphopenia (75.4%), periodic fever (66.7%), and developmental delay (60.0%). In addition to the typical tetralogy, SIFD features several heterogeneous symptoms involving multiple systems. Corticosteroids, immunosuppressants, and anakinra have low efficacy, whereas etanercept suppressed fever and improved anemia in reports. Bone-marrow transplantation can be used to treat severe SIFD, but carries a high risk. In total, 28.2% (20/71) of reported patients died, mainly because of multi-organ failure. Biallelic mutations located in exon1-intron5 lead to more severe phenotypes and higher mortality. Furthermore, 15.5% (11/71) patients survived to adulthood. The symptoms could be resolved spontaneously in five patients. Conclusions: Thalidomide can control the inflammation of SIFD and represents a new treatment for SIFD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Trends of therapy in the treatment of asthma.
- Author
-
Lv, Xiaodi, Gao, Zhen, Tang, Weifeng, Qin, Jingjing, Wang, Wenqian, Liu, Jiaqi, Li, Mihui, Teng, Fangzhou, Yi, La, Dong, Jingcheng, and Wei, Ying
- Subjects
ASTHMA ,BIBLIOMETRICS ,ANTIASTHMATIC agents ,SCHOLARLY periodicals ,PSEUDOPOTENTIAL method - Abstract
Background: To better understand the development of therapy for asthma, grasp the core paradigm associated with the transformation of cognition of asthma treatment and asthma, explore potential and effective therapies for asthma, discover new biomarkers and mechanisms related to asthma treatment, find novel targets for anti-asthma drugs, and predict the future trends of asthma therapy, we used a bibliometric analysis to research articles related to the therapies for asthma published from 1983 to 2022. Methods: A comprehensive search was conducted to analyze the articles associated with therapy for asthma with the help of the Web of Science Core Collection (WOSCC) database from January 1, 1983 to August 14, 2022. The CiteSpace 6.1.R2 software and VOS viewer 6.1.8 software were utilized to analyze the overall structure of the network, network clusters, links between clusters, key nodes, and pathways. Results: A total of 3902 publications related to therapies on asthma were published in 3211 academic journals by a total of 14,655 authors in 3476 organizations from 87 countries or regions from 1983 to 2022. The United States published the most articles (n = 1143), followed by England (n = 574) and China (n = 405). However, the centrality of China was 0.4, higher than the United States (centrality = 0.16) and Singapore (centrality = 0.11). Akdis Cezmi published the most papers. Journal of Allergy and Clinical Immunology published the most studies on therapies for asthma. Asthma was the most frequent keyword (n = 594). The betweenness centrality value of keywords that were greater than 0.1 included airway inflammation (centrality = 0.22), double blind (centrality = 0.18), asthma (centrality = 0.17), inflammation (centrality = 0.12), and inhaled corticosteroid (centrality = 0.11). Conclusions: The results from this biometric review provide insight into the development of therapy for asthma, the paradigm of recognition of this field, the approach of discovering new targets, exploration and combination of new mechanisms, and the frontier trend of this field in future. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Current and Future Therapeutical Options in Alport Syndrome.
- Author
-
Reiterová, Jana and Tesař, Vladimír
- Subjects
- *
HEREDITY , *ENDOTHELIN receptors , *CHRONIC kidney failure , *FOCAL segmental glomerulosclerosis , *ANGIOTENSIN receptors , *GENETIC disorders - Abstract
Alport syndrome (AS) is a hereditary kidney disease caused by pathogenic variants in COL4A3 and COL4A4 genes with autosomal recessive or autosomal dominant transmission or in the COL4A5 gene with X-linked inheritance. Digenic inheritance was also described. Clinically it is associated with microscopic hematuria, followed by proteinuria and chronic renal insufficiency with end-stage renal disease in young adults. Nowadays, there is no curative treatment available. The inhibitors of RAS (renin-angiotensin system) since childhood slow the progression of the disease. Sodium-glucose cotransporter-2 inhibitors seem to be promising drugs from DAPA-CKD (dapagliflozin–chronic kidney disease) study, but only a limited number of patients with Alport syndrome was included. Endothelin type A receptor and angiotensin II type 1 receptor combined inhibitors, and lipid-lowering agents are used in ongoing studies in patients with AS and focal segmental glomerulosclerosis (FSGS). Hydroxychloroquine in AS is studied in a clinical trial in China. Molecular genetic diagnosis of AS is crucial not only for prognosis prediction but also for future therapeutic options. Different types of mutations will require various types of gene, RNA, or protein therapy to improve the function, the of final protein product. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Guidelines for diagnosis and treatment of chronic gastritis in China (2022, Shanghai).
- Subjects
- *
GASTRITIS , *GASTRIC mucosa , *PRECANCEROUS conditions , *SYMPTOMS , *DIAGNOSIS , *PHYSICIANS - Abstract
Chronic gastritis is a commonly seen disease; clinicians have always attached to the importance of understanding its etiology and clinical manifestations, standardizing its diagnosis and treatment, and preventing its progression to cancers. Based on the consensus opinions on the diagnosis and treatment of chronic gastritis in the past three editions, and referring to the international consensuses and guidelines on the management of precancerous lesions of gastric mucosa, it is of clinical value and feasibility to formulate the guidelines for the diagnosis and treatment of chronic gastritis in line with China's national conditions. This guideline was initiated by the Chinese Society of Gastroenterology, with major members of the Cancer Collaboration Group of Chinese Society of Gastroenterology serving as the convenors and authors. Based on the internationally accepted principles and methods of guideline development and the extensive collection of opinions from gastroenterologists and physicians, 53 evidence‐based recommendations are given for nine major clinical problems related to chronic gastritis, aiming to improve the diagnosis, treatment, and management of chronic gastritis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project
- Author
-
Wang, Yintang, Geng, Yu, Zhang, Ou, Xu, Qin, Xue, Yajun, Zhou, Boda, Zhang, Ping, the CCC-ACS Investigators, Li, Aihua, Li, Bao, Xu, Biao, Han, Guangshu, Li, Bin, Liu, Bin, Wang, Bin, Fu, Bing, Yu, Bo, Yang, Bosong, Luo, Caidong, and Wang, Changqian
- Subjects
ACUTE coronary syndrome ,CARDIOVASCULAR diseases ,CORONARY disease ,CORONARY care units ,MAJOR adverse cardiovascular events ,PROPORTIONAL hazards models ,HOSPITAL mortality ,PRASUGREL - Abstract
Background: The association between P2Y12 receptor inhibitors reloading and in-hospital outcomes in non-ST-segment elevation acute coronary syndrome (NSTEACS) patients who were on chronic P2Y12 receptor inhibitors therapy remained underdetermined. Methods: The Improving Care for Cardiovascular Disease in China–Acute Coronary Syndrome (CCC–ACS project) is a national registry active from November 2014 to December 2019. 4790 NSTEACS patients on chronic P2Y12 receptor inhibitors therapy were included. Cox proportional hazard models, Kaplan–Meier curves, and subgroup analyses were conducted. Results: The NSTEACS patients who received reloading of P2Y12 receptor inhibitors were younger and had fewer comorbid conditions. The reloading group had a lower risk of major adverse cardiac events (MACE) (0.51% vs. 1.43%, P = 0.007), and all-cause death (0.36% vs. 0.99%, P = 0.028), the risks of myocardial infarction and major bleeding were not significantly different between patients with and without reloading. In survival analysis, a lower cumulative risk of MACE could be identified (Log-rank test, P = 0.007) in reloading group. In the unadjusted Cox model, reloading P2Y12 receptor inhibitors was associated with a decreased risk of MACE [HR, 0.35; 95% CI 0.16–0.78; (P = 0.010)] and all-cause death [HR, 0.37; 95% CI 0.14–0.94; (P = 0.036)]. Reloading of P2Y12 receptor inhibitors was associated with a decreased risk of MACE in most of the subgroups. Conclusions: In NSTEACS patients already taking P2Y12 receptor inhibitors, we observed a decreased risk of in-hospital MACEs and all-cause mortality and did not observe an increased risk of major bleeding, with reloading. The differential profile in the two groups might influence this association and further studies are warranted. Clinical trial registration: https://www.clinicaltrials.gov (Unique identifier: NCT02306616, date of first registration: 03/12/2014) [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance.
- Author
-
Shirvani, Hanieh, Jafari, Hanieh, Moravveji, Sayyed Sajjad, Abbasi Faranghizadeh, Fatemeh, Talebi, Mehrdad, Ghanavi, Jalaledin, Esfandi, Farbod, Najafi, Sajad, Nasiri Moghadam, Masomeh, Farnia, Poopak, and Aghaei Zarch, Seyed Mohsen
- Subjects
- *
NON-coding RNA , *SARS-CoV-2 , *PATHOGENIC viruses , *VIRUS diseases , *MOLECULAR biology - Abstract
The recently developed pathogenic virus, SARS-CoV-2, was found in the Hubei Province, China. Giving rise to a broad spectrum of symptoms, SARS-CoV-2 rapidly spread across the globe, causing multi-systemic and dangerous complications, with death in extreme cases. Thereby, the number of research cases increases every day on preventing infection and treating its resulting damage. Accumulating evidence suggests noncoding RNAs (ncRNAs) are necessary for modifying virus infection and antiviral immune reaction, along with biological processes regulating SARS-CoV-2 and subsequent disease states. Therefore, understanding these mechanisms might provide a further understanding of the pathogenesis and feasible therapy alternatives against SARS-CoV2. Consequently, the molecular biology of SARS-CoV-2, ncRNA's role in its infection, and various RNA therapy tactics against the virus have been presented in this review section. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
26. Gastroesophageal reflux disease: When East meets West.
- Subjects
- *
GASTROESOPHAGEAL reflux , *PROTON pump inhibitors , *POTASSIUM channels , *CATHETER ablation , *FUNDOPLICATION - Abstract
Gastroesophageal reflux disease (GERD) is common worldwide and poses a huge challenge to health. Consensuses and guidelines on the diagnosis and management of GERD in China and the USA have recently been updated. The divergence between these guidelines indicates the differences in the conception of this disease by experts in different countries, and is influenced by available medications and interventional procedures. Prompt endoscopy has been advocated in China due to a high prevalence of upper gastrointestinal (GI) cancer, while endoscopy has been reserved for those who are at a risk of malignancy or who are reisitant to proton pump inhibitors (PPIs) in the USA. A potassium channel acid‐blocker is widely used in Asian countries and has proven efficacy. Moreover, it has been recommended, together with PPIs, as a primary therapy for GERD in China; while PPI alone is recommended as a first‐line treatment in the USA. Although more prokinetics are available in China than in the USA and can alleviate GERD symptoms when combined with PPI, the choice of prokinetics is limited in the USA, leading to completely opposite attitudes to prokinetics in the two countries. Novel anti‐reflux procedures have been introduced in both countries. Transoral incisionless fundoplication (TIF) is recommended as an endoscopic anti‐reflux procedure, and magnetic sphincter augmentation (MSA) is recognized as equivocal to conventional laparoscopic fundoplication in the USA. However, radiofrequency ablation is more popular in China, and clinical trials on TIF and MSA are not complete, which results in diverse opinions about suitable anti‐reflux procedures in China. A comparison of the guidelines may therefore shed light on the multiple dimensions of GERD and thus deepen our understanding of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Researchers from University of Electronic Science and Technology of China Discuss Findings in B-Cell Lymphoma (Benefit of Consolidative Radiation In Patients With Extranodal Limited-stage Diffuse Large B-cell Lymphoma: a Multicenter...).
- Subjects
DIFFUSE large B-cell lymphomas ,LYMPHOMAS ,RESEARCH personnel - Abstract
A recent study conducted by researchers from the University of Electronic Science and Technology of China examined the benefits of consolidative radiation therapy in patients with extranodal limited-stage diffuse large B-cell lymphoma (LS-DLBCL). LS-DLBCL is a type of lymphoma that affects approximately 40% of patients with limited-stage disease. The study found that the addition of consolidative radiation therapy to rituximab-based chemoimmunotherapy improved overall survival and progression-free survival in these patients. The results suggest that consolidative radiation therapy may be a valuable treatment option for patients with extranodal LS-DLBCL. [Extracted from the article]
- Published
- 2024
28. China Transcatheter Aortic Valve Replacement TAVR & Transcatheter Mitral Valve TMV Market Insights & Forecasts 2024-2028 - ResearchAndMarkets.com.
- Subjects
HEART valve prosthesis implantation ,MITRAL valve ,SARS-CoV-2 ,MARKETING forecasting - Abstract
A report titled "China TAVR & TMV Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" has been added to ResearchAndMarkets.com's offerings. The report predicts that the China TAVR market will reach US$4.04 billion by 2028, growing at a CAGR of 55.55% from 2024-2028. The TMV market in China is also expected to rise to US$4515.5 million by 2028, with a CAGR of 146.50% from 2024-2028. Factors driving this growth include the increasing prevalence of aortic stenosis, the approval of new TAVR products, the rise in the geriatric population, and rapid urbanization. However, challenges such as risks associated with TAVR procedures and patient selection in TMVI may hinder market growth. The report also highlights trends such as the rising penetration of TAVR and TMV procedures, declining prices of transcatheter mitral valve procedures, upcoming major TMVI products, and an increase in complications in open-heart surgery. The development of interventional heart valve therapy is considered a safe and minimally invasive treatment for elderly patients with high surgical risks and poor health. The report emphasizes the broadening indications for interventional therapy and the growing number of medical device companies participating in R&D of transcatheter heart valve repair and replacement products in China. The report provides a [Extracted from the article]
- Published
- 2024
29. Patient-level comparison of heart failure patients in clinical phenotype and prognosis from China and Sweden.
- Author
-
Feng, Yizhou, Chen, Xiaojing, Schaufelberger, Maria, Zhang, Qing, and Fu, Michael
- Subjects
HEART failure patients ,HEART valve diseases ,CORONARY disease ,CARDIAC patients ,SYSTOLIC blood pressure - Abstract
Background: Clinical phenotype and prognosis of heart failure (HF) may be variable among different racial populations. Therefore, a patient-level comparison of hospitalized HF patients in two university hospitals from China and Sweden was performed.Methods and Results: This study was a pooled data analysis of the patients prospectively enrolled in two single-center studies in China (n = 949) and Sweden (n = 1639) from 2011 to 2015. Clinical characteristics and 6-month all-cause mortality were collected. Higher systolic blood pressure (126.1 ± 20.3 vs. 114.2 ± 15.4 mmHg, p < 0.001) and NT-proBNP level (4540 vs. 3251 pg/mL, p = 0.013) were found in the Swedish cohort, also more patients with ischemic heart disease (32.0% vs. 19.2%), hypertension (64.2% vs. 36.8%), valvular heart disease (40.9% vs.31.6%) and atrial fibrillation (55.3% vs. 39.6%) (all p < 0.001). The use of ACEIs/ARBs (48.8% vs. 80.8%) or beta-blockers (58.8% vs. 86.5%) (both p < 0.001) was lower in Chinese cohort. Given younger age in Chinese cohort (61.6 vs. 76.4 years, p < 0.001), age-stratified analyses were conducted, as there were similar patient numbers in 50-74 years in Chinese (n = 550) and Swedish (n = 554) cohorts, therefore baseline characteristics and prognosis were further compared. The age- and sex-adjusted outcome (HR 0.80 [95% CI 0.55-1.19], p = 0.273) was comparable between the two populations. The NT-proBNP and eGFR independently predicted 6-month mortality in both Chinese (HR [95% CI] 1.006 [1.003-1.008], 0.986 [0.976-0.999]) and Swedish cohort (1.003 [1.000-1.007], 0.988 [0.976-0.999]).Conclusions: Patient-level comparison of real-world HF populations from China and Sweden demonstrated different clinical phenotypes and therapy but similar prognosis and their predictors. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
30. Acute liver failure caused by Amanita verna: a case series and review of the literature.
- Author
-
Wu, Jianlong, Gong, Xueyi, Hu, Zemin, and Sun, Qiang
- Subjects
LIVER failure ,DISSEMINATED intravascular coagulation ,SYMPTOMS ,LITERATURE reviews ,LIVER transplantation ,DRUG toxicity ,POSTOPERATIVE nausea & vomiting - Abstract
Background: Amanita verna is one of the most harmful wild fungi in China. Amanita verna poisoning occurs every year, and the mortality is as high as 50%. However, its clinical manifestations are complex and diverse.Case Presentation: In March 2019, three patients took a large amount of Amanita, and one of them received liver transplantation in Zhongshan hospital, Sun Yat-sen University. All patients had vomiting and diarrhea 8-12 h after eating wild mushrooms (Amanita). The patients were initially diagnosed with Amanita poisoning. One case (case 3) was complicated and diagnosed as mushroom poisoning (fatal Amanita), toxic hepatitis, acute liver failure, toxic encephalopathy, hemorrhagic colitis, toxic myocarditis, disseminated intravascular coagulation (DIC) and pregnancy. The general clinical data of all patients were recorded, who received early treatment such as hemodialysis, artificial liver plasma exchange, hormone shock and anti-infection. One case (case 1) recovered smoothly after liver transplantation, and the indexes of liver, kidney, coagulation function and infection were improved. The other two cases died of intracerebral hemorrhage.Conclusion: Liver transplantation is an effective method for the treatment of acute liver failure caused by mushroom poisoning and can improve the survival rate of patients with toxic liver failure. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
31. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020.
- Author
-
Tang, Xue, Gao, Ju, Ma, Zhi-gui, Guo, Xia, Li, Qiang, Wan, Zhi, and Sun, Jing-jing
- Subjects
LANGERHANS-cell histiocytosis ,CHILD patients ,MITOGEN-activated protein kinases ,GROWTH disorders ,DIABETES insipidus ,VEMURAFENIB - Abstract
This study aimed to understand the clinical characteristics and outcomes of children with Langerhans cell histiocytosis (LCH) in China. We conducted a retrospective study of 95 paediatric patients with LCH in West China Second University Hospital of Sichuan University between July 2013 and August 2020. The onset age of multisystem LCH (MS-LCH) patients with risk organ (RO) involvement was younger than that of MS-LCH without RO involvement (p =.002) and single system LCH (p <.001) patients; bone was the most frequently involved organ, followed by the skin. Of all, the BRAF-V600E mutation was detected in 48 out of 84 patients who underwent gene analysis. Additionally, in our study, BRAF p.N486_T491 > K, BRAF p.L485_P490delinsF, BRAF p.R506_K507insLLR, ARAF p.Q349_F351delinsL and MAP2K1 p.Q58_E62del were known mutations in the mitogen-activated protein kinase (MAPK) pathway. The BRAF-V600E genotype in the tissue and plasma prior to therapy were detected in 16 patients, and the concordance was only 37.5% (6/16). According to the modified LCH-III-based-protocol, JLSG-02 protocol chemotherapy, and vemurafenib, the estimated five-year overall survival, event-free survival (EFS) and cumulative reactivation rates of 95 patients were 98.8%, 74.6% and 24.5%, respectively. The EFS rate in good responders was better than that in poor responders at 12-week (HR = 0.022, 95%CI 0.002–0.231, p =.002), and EFS was not affected by age, RO involvement or BRAF-V600E mutation. Regarding sequelae, nine patients had central diabetes insipidus and two had growth retardation. In this study, LCH was a highly heterogeneous disease characterized molecularly by MAPK-pathway activating mutations. Vincristine, prednisone and cytarabine-based chemotherapy combined with vemurafenib improved the prognosis of childhood LCH. In future, prospective clinical trials and novel therapeutic strategies should be developed to improve outcomes in paediatric patients with LCH. Children with Langerhans cell histiocytosis in China present highly heterogeneous clinical characteristics, with up to 60% of cases harbouring mutations in MAPK pathway. Treatment response at 12-week is associated with EFS in our study. Vincristine, prednisone and cytarabine-based chemotherapy combined with vemurafenib improved the prognosis of Chinese childhood LCH, but the reactivation rate is still high. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
32. The Correlation Between UGT1A1 Gene Phenotypes and the Clinical Prognosis of Advanced Colorectal Cancer After FOLFIRI Therapy.
- Author
-
Li, Xiao-Kai, Wang, Wen-Ling, Xu, Yu-Xuan, Yang, Yuan, Wang, Gang, Dong, Hong-Min, Chen, Wei-Wei, and Li, Guo-Dong
- Subjects
- *
DIAGNOSIS of blood diseases , *FOLINIC acid , *DIGESTIVE system diseases , *ANTINEOPLASTIC agents , *CAMPTOTHECIN , *RETROSPECTIVE studies , *PROGNOSIS , *COLORECTAL cancer , *FLUOROURACIL , *RISK assessment , *TUMOR classification , *TRANSFERASES , *BLOOD diseases , *RADIOTHERAPY , *DRUG side effects , *DRUG resistance in cancer cells ,DIAGNOSIS of digestive system diseases - Abstract
Objective: This study investigated the correlations between the different phenotypes of the uridine diphosphate glucuronyl transferase (UGT) 1A1 gene and the treatment of advanced colorectal cancer after the FOLFIRI regimen. Materials and Methods: A total of 240 advanced colorectal cancer patients with stage IV colon cancer or recurrence after radical surgery between January 2014 and December 2018 were included in a retrospective study. All participants were treated with the FOLFIRI regimen until the disease progressed or an intolerable level of toxicity occurred. Results: In this study, three phenotypes of the UGT1A1 gene promoter were found: the homozygous wild type (TA6/6 type, 78.3%), the heterozygous mutant type (TA6/7 type, 19.6%), and the homozygous mutant type (TA7/7 type, 2.1%). Compared with TA6/7 and TA6/6, the risk of nonresponse to FOLFIRI chemotherapy increased by 16%, but the difference was not significant. The risk of death increased by 24%, and there was no significant difference. There was a risk of hematologic and nonhematologic adverse reactions occurring in TA6/7 and TA6/6, and the total risk of adverse reactions increased by 9.3773 times among patients with more than two metastatic organs. Compared with patients with TA6/6, the risk of toxic side-effects increased by 42.8066 times (p = 0.0259) for patients with TA6/7. Among patients who received FOLFIRI chemotherapy for more than four cycles, the proportion with TA6/7 was greater than that with TA6/6. Compared with those with TA6/6, patients with TA6/7 showed a higher risk of hematologic toxicity (22.3246 times, p = 0.0035). Conclusion: The TA6/7 in patients with advanced colorectal cancer had more than two metastatic organs, and received FOLFIRI chemotherapy for more than four cycles compared with TA6/6 patients. Furthermore, the risk of hematologic and nonhematologic adverse reactions significantly increased, and the risk of digestive-tract and hematologic toxicity was more significant. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
33. Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Mild Cognitive Impairment: A Meta-Analysis of Randomized Controlled Trials.
- Author
-
Zhang, Xinqi, Lan, Xiaoyong, Chen, Chanjuan, Ren, Huixia, and Guo, Yi
- Subjects
BRAIN stimulation ,TRANSCRANIAL magnetic stimulation ,MILD cognitive impairment ,RANDOMIZED controlled trials ,COGNITIVE ability ,ALZHEIMER'S patients - Abstract
Background: Mild cognitive impairment (MCI) is an intermediary state between normal aging and dementia. It has a high risk of progression in patients with Alzheimer's disease (AD). Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique used to improve cognitive deficits in patients with MCI and AD. Although previous meta-analyses included studies carried on patients with MCI and AD, few studies have analyzed patients with MCI independently. This meta-analysis aimed to evaluate the effects and safety of rTMS on cognition function in patients with MCI and factors that may influence such effects. Methods: Data used in this study were searched and screened from different databases, including PubMed, Web of Science, Embase, the Cochrane Library, Chinese National Knowledge Infrastructure (CNKI), Chinese Technical Periodicals (VIP), Wanfang Database, and China BioMedical Literature Database (SinoMed). The retrieved studies were carefully reviewed, data were extracted, and the quality of data was assessed. Results: A total of 12 studies involving 329 patients with MCI were included in the present meta-analysis. The analyses results revealed that rTMS improved cognitive function [standardized mean difference (SMD) = 0.83, 95% confidence interval (CI) = 0.44–1.22, p = 0.0009] and memory function (SMD = 0.73, 95% CI = 0.48–0.97, p < 0.00001) in the MCI + rTMS active group when compared to the sham stimulation group. The showed that: (1) cognitive improvement was more pronounced under high-frequency rTMS stimulation of multiple sites, such as the bilateral dorsolateral prefrontal cortex and (2) more than 10 rTMS stimulation sessions produced higher improvement on cognition function in patients with MCI. Conclusions: This study shows that rTMS can improve cognitive function in patients with MCI, especially when applied at high frequency, multi-site, and for a prolonged period. However, further studies are required to validate these findings and explore more effective stimulation protocols and targets. Systematic Review Registration: [http://www.crd.york.ac.uk/PROSPERO/], identifier: CRD 42021238708. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
34. Chinese consensus on the management of liver cirrhosis.
- Subjects
- Humans, China, Prognosis, Liver Cirrhosis complications, Liver Cirrhosis therapy, Consensus
- Abstract
Liver cirrhosis, characterized by diffuse necrosis, insufficient regeneration of hepatocytes, angiogenesis, severe fibrosis, and the formation of pseudolobules, is a progressive, chronic liver disease induced by a variety of causes. It is clinically characterized by liver function damage and portal hypertension, and many complications may occur in its late stage. Based on the updated practice guidelines, expert consensuses, and research advances on the diagnosis and treatment of cirrhosis, the Chinese Society of Gastroenterology of Chinese Medical Association established the current consensus to standardize the clinical diagnosis and management of liver cirrhosis and guide clinical practice. This consensus contains 43 statements on the etiology, pathology and pathogenesis, clinical manifestations, major complications, diagnosis, treatment, prognosis, and chronic disease control of liver cirrhosis. Since several practice guidelines and expert consensuses on the complications of liver cirrhosis have been published, this consensus emphasizes the research progress of liver cirrhosis itself., (© 2024 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
35. Pathway to Approval of Innovative Radiopharmaceuticals in China.
- Author
-
An S, Wang L, Xie F, Jiang D, Huang G, Liu J, Ma X, and Wei W
- Subjects
- China, Humans, Radiopharmaceuticals therapeutic use, Drug Approval
- Abstract
Since the late 1950s, radiopharmaceuticals have been used for diagnosis and treatment in clinical nuclear medicine in China. Over the decades, China has successfully established a relatively sophisticated system for radiopharmaceutical production and management, supported by state-of-the-art facilities. With the rapid growth of the national economy, the radiopharmaceutical market in China is expanding at a remarkable pace. This burgeoning market has led to an escalating demand for clinical-stage radiopharmaceuticals, either produced domestically or imported. Despite this positive trajectory, the development and application of radiopharmaceuticals in China have been hindered by several challenges that persist, such as inadequate research, insufficient investment, limited availability of radionuclides, shortage of trained personnel in related fields, and imperfections in policies and regulations. In an exciting development, the regulation reforms implemented since 2015 have positively affected China's drug regulatory system. The introduction of the "Mid- and Long-Term Development Plan (2021-2035) for Medical Isotopes" created concurrently an opportune environment for the advancement of innovative radiopharmaceuticals. In this review, we aim to provide an overview of the approval process for novel radiopharmaceuticals by the National Medical Products Administration and the status of radiopharmaceuticals in research and development in China. Preclinical development and clinical translation of radiopharmaceuticals are undergoing rapid evolution in China. As practitioners in the field in China, we provide several practical suggestions to stimulate open discussions and thoughtful consideration., (© 2024 by the Society of Nuclear Medicine and Molecular Imaging.)
- Published
- 2024
- Full Text
- View/download PDF
36. Clinical efficacy of intense pulsed light combined with low-dose intralesional corticosteroids in treating noninfectious granulomas after mesotherapy: A case series analysis.
- Author
-
Wang J, Chen Z, Zhou C, and Yu B
- Subjects
- Humans, Female, Retrospective Studies, Adult, Treatment Outcome, Combined Modality Therapy adverse effects, Combined Modality Therapy methods, Middle Aged, Intense Pulsed Light Therapy adverse effects, Male, Adrenal Cortex Hormones administration & dosage, Adrenal Cortex Hormones adverse effects, China, Mesotherapy adverse effects, Injections, Intralesional, Granuloma etiology, Granuloma drug therapy, Patient Satisfaction
- Abstract
Background: Mesotherapy is a popular cosmetic procedure for localized delivery of substances. However, due to the lack of standardized processes, there are potential risks of adverse reactions. Granulomas formation is one of the chronic reactions which impose significant physical and mental burdens on patients., Objectives: The aim of this analysis is to evaluate the safety and feasibility of combining intense pulsed light (IPL) with intralesional corticosteroids for treating noninfectious granulomas after mesotherapy., Methods: This retrospective observational case series included patients who suffer from noninfectious granulomas after mesotherapy and received combination of IPL and intralesional corticosteroids treatment between October 2021 and December 2022 at Peking University Shenzhen Hospital, Shenzhen, China. The process and effect were analyzed and summarized., Results: Among the seven patients, five expressed extreme satisfaction with the efficacy, while two was slightly satisfied. The physicians believed that all patients had shown significant improvement. No adverse reactions or recurrences were observed during follow-up., Conclusion: Based on this analysis, the application of the combined treatment in patients suffering from noninfectious granuloma due to mesotherapy demonstrates good clinical efficacy and safety, making it worth considering as a treatment option., (© 2024 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
37. [Chinese expert consensus on the diagnosis and management of elderly patients with diffuse large B-cell lymphoma (2024)].
- Subjects
- Humans, Aged, China, Lymphoma, Large B-Cell, Diffuse diagnosis, Lymphoma, Large B-Cell, Diffuse therapy, Consensus
- Abstract
The general population in China is aging, and thus the number of older patients with diffuse large B-cell lymphoma (DLBCL) will continue to increase. Individualized treatment is required to maximize therapeutic potential while minimizing the risk of toxicity. To improve the diagnosis and treatment of DLBCL in older people in China, the Lymphocyte Disease Group of the Hematology Division of the Chinese Medical Association and Lymphoma Expert Commitee of Chinese Society of Clinical Oncology (CSCO) have organized relevant experts to formulate this consensus.
- Published
- 2024
- Full Text
- View/download PDF
38. The Comparative Influence of 2 and 4 Weeks Preoperative Antituberculosis Treatment on Spinal Tuberculosis Surgery: A Multicenter, Prospective, Randomized Clinical Trial.
- Author
-
Fan, Jun, Lan, Tinglong, Tang, Kai, Wang, Guirong, Dong, Weijie, Li, Dawei, Yan, Guangxuan, Li, Yuan, Lei, Guohua, Shan, Jianlin, Wang, Qinglei, Ma, Jianhua, Huang, Hairong, and Qin, Shibing
- Subjects
- *
SPINAL tuberculosis , *CLINICAL trials , *TUBERCULOSIS patients , *SPINAL fusion , *OPERATIVE surgery , *TUBERCULOSIS , *SPINAL surgery - Abstract
Introduction: A trade-off between successful surgery and minimizing the operation delay for patients with spinal tuberculosis (TB) is a major consideration to determine the duration of preoperational anti-TB treatment (AAT). In this study, 2 and 4 weeks preoperative AAT durations were compared for their influence on the operation outcomes. Method: A multicenter, prospective, randomized trial was conducted in four hospitals in China. New patients with spinal TB were recruited and randomly allocated to two groups (2 or 4 weeks' preoperative treatment) and administered the standardized first-line anti-TB drugs. The symptom changing and indicators reflecting recovery and side effects of the treatment were monitored. Patient was followed up for another 18 months after completion of treatment. Results: In total, 150 eligible patients were enrolled between June 2014 and December 2016, and 13 patients were excluded after the enrollment. The remaining 137 participants were randomly allocated to the 2-week group (n = 68) or the 4-week group (n = 69). These two groups acquired similar surgical outcomes, considering wound healing rate within 3 months after the operation (94.20%, 65/69 vs 89.71%, 61/68; P = 0.333) and bony fusion rate within 6 months (98.46%, 64/65 vs 95.45%, 63/66; P = 0.317). However, the culture positive rate of pus collected during operation in the 4-week group (41.94%) was significantly lower than that of the 2-week group (60.94%, P = 0.033). No reoccurrence of disease was observed in either group during the 18-month follow-up period. Conclusion: Patients with spinal TB administered 2 or 4 weeks of preoperative anti-TB treatment acquired similar surgical outcomes. However, patients who underwent the operation sooner suffered 2 weeks less agony from the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Research on esophageal cancer: With personal perspectives from studies in China and Kenya.
- Author
-
Yang, Chung S. and Chen, Xiaoxin Luke
- Subjects
PRECANCEROUS conditions ,ESOPHAGEAL cancer ,TOBACCO use ,FOOD consumption ,SQUAMOUS cell carcinoma ,CANCER research ,BEVERAGE consumption - Abstract
The most common form of esophageal cancer (EC), esophageal squamous cell carcinoma (ESCC), is prevalent in many unindustrialized societies, among people with lower socioeconomic status and those who frequently use tobacco and alcohol. In some areas, ESCC mortality ranked top among all cancer. In this review, we begin with discussions of the extensive research on EC in Linxian in northern China that started 60 years ago and the recent studies in Kenya from our personal perspectives. Based on the results obtained from these studies and information from the literature, we summarize our current understanding about the risk factors for ESCC including lifestyle factors (smoking, alcohol, consumption of food and beverages at high temperature and other unhealthy habits), poor diet and nutritional insufficiencies and genetic susceptibility. Elimination or minimization of these environmental risk factors, as well as early detection and treatment of precancerous lesions, would be effective means for the prevention of ESCC. Current knowledge of molecular alterations in ESCC (gene mutations, hypermethylation and amplification or overexpression), as well as treatment of ESCC and the potential of targeted therapy, are also discussed. Finally, we propose effective approaches for the prevention of ESCC by adapting a healthy lifestyle, including a healthy diet that would also prevent other diseases. Community outreach, public education and international collaboration are important for achieving this public health goal. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
40. Clinical Characteristics and Optimal Therapy of Acute Myeloid Leukemia with Myelodysplasia-Related Changes: A Retrospective Analysis of a Cohort of Chinese Patients.
- Author
-
Lei Wang, Xiaoxia Chu, Jingyao Wang, Licai An, Yinghui Liu, Li Li, and Junqing Xu
- Subjects
- *
THERAPEUTIC use of antineoplastic agents , *MYELODYSPLASTIC syndromes , *GRANULOCYTE-colony stimulating factor , *MULTIVARIATE analysis , *ACUTE myeloid leukemia , *RETROSPECTIVE studies , *AMINOGLYCOSIDES , *TREATMENT effectiveness , *CANCER patients , *COMPARATIVE studies , *IDARUBICIN , *DECITABINE , *SURVIVAL analysis (Biometry) , *DESCRIPTIVE statistics , *LACTATE dehydrogenase , *CYTARABINE , *DAUNOMYCIN , *LONGITUDINAL method , *DISEASE remission , *SYMPTOMS , *MIDDLE age , *OLD age - Abstract
Objective: This study aimed to investigate the clinical characteristics of acute myeloid leukemia with myelodysplasia-related changes (AMLMRC) according to the 2016 World Health Organization classification and the preferred therapy for patients with AML-MRC aged 60-75 years. Materials and Methods: We retrospectively analyzed differences in clinical data among 190 patients with AML-MRC and 667 patients with AML not otherwise specified (AML-NOS). We also compared different therapeutic regimens among patients with AML-MRC aged 60-75 years. Results: Compared with AML-NOS, patients with AML-MRC had significantly different clinical characteristics as well as worse overall survival (OS) (9.2 vs. 13.6 months; p<0.001) and complete remission rates (65.3% vs. 76.2%; p=0.005). Multivariate analysis performed for the whole group (patients with both AML-MRC and AML-NOS) showed that AML-MRC was the independent prognostic factor (p=0.002). Additional multivariate analysis performed for 190 patients with AML-MRC indicated that age (p<0.001) and lactate dehydrogenase (p=0.031) were independent prognostic factors. Compared with the IA/DA regimen [idarubicin and cytarabine (IA) or daunorubicin and cytarabine (DA)], the DAC+CAG regimen [decitabine and half-dose CAG regimen (cytarabine, aclarubicin, and granulocyte colony-stimulating factor)] was associated with better OS (4.5 vs. 6.2 months; p=0.021) in patients aged 60-75 years and categorized into the unfavorable risk group. Conclusion: AML-MRC cases exhibited worse clinical outcomes compared to AML-NOS. Compared to the IA/DA regimen, the DAC+CAG regimen was the optimal choice for patients with AMLMRC in the unfavorable risk group and aged 60-75 years. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
41. Effects of Sodium Valproate Monotherapy on Blood Liver Enzyme Levels in Patients with Epilepsy: A Meta-Analysis.
- Author
-
Fu, Jie, Tao, Tao, Li, Zuoxiao, Chen, Yangmei, Chen, Xiu, Li, Jinglun, and Peng, Lilei
- Subjects
- *
VALPROIC acid , *LIVER enzymes , *PEOPLE with epilepsy , *ASIANS , *GAMMA-glutamyltransferase , *DATABASE searching , *PHENOBARBITAL - Abstract
We conducted this meta-analysis to assess the effects of sodium valproate (VPA) monotherapy on blood liver enzymes in patients with epilepsy. PubMed, Web of Science, EBSCO, Cochrane Library, Wanfang, China national knowledge infrastructure databases were searched. Nine studies were included. Results showed: (1) The overall SMD for blood AST, ALT, and GGT levels of VPA monotherapy group versus control group were 0.70 (95% CI=0.31 to 1.09, Z=3.52, p=0.0004), 0.47 (95% CI=− 0.01 to 0.95, Z=1.91, p=0.06), 0.44 (95% CI=0.29 to 0.60, Z=5.55, p<0.00001), respectively. (2) In subgroup meta-analysis, increased blood AST and GGT levels were observed in epileptic minors (AST: total SMD=0.85, 95% CI=0.40 to 1.30, Z=3.69, p=0.0002; GGT: total SMD=0.46, 95% CI=0.29 to 0.63, Z=5.25, p<0.00001). Elevated blood ALT level was observed in Asian patients receiving VPA monotherapy (total SMD=0.70, 95% CI=0.51 to 0.90, Z=7.01, p<0.00001), and the early stage of VPA monotherapy (total SMD=0.93, 95% CI=0.57 to 1.29, Z=5.09, p<0.00001). Overall, our results indicated that blood AST and GGT were significantly increased in epileptic minors receiving VPA monotherapy. The elevation of blood ALT was observed in Asian patients and the early stage of VPA monotherapy. However, due to the small number of included studies, our results should be considered with caution. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
42. No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.
- Author
-
Wang, Lulu, Wang, Shumin, Yang, Haonan, Han, Jiaojiao, Zhao, Xue, Han, Sensen, Zhang, Yingna, Lv, Jie, Zhang, Jing, Li, Mingqiang, Ji, Ying, Zhou, Shuxian, He, Xiaoxiao, Fang, Hua, Yang, Junhong, Zhang, Yunke, Zhang, Qingyong, Gao, Peiyang, and Gao, Feng
- Subjects
- *
MYASTHENIA gravis , *CHOLINERGIC receptors , *RECEPTOR antibodies , *SYMPTOMS , *RANK correlation (Statistics) , *IMMUNOSUPPRESSIVE agents - Abstract
Objective: To investigate the correlation between acetylcholine receptor antibodies (AChR‐Ab) concentration levels and individualized clinical symptoms in patients with AChR myasthenia gravis (AChR‐MG) in China. Methods: ELISA was used to determine the concentration of AChR‐Ab in patients with MG. The Myasthenia Gravis Foundation of America (MGFA) Clinical Classification, Quantitative Myasthenia Gravis (QMG) score, and MG‐specific activities of daily living (MG‐ADL) scoring systems were used to evaluate the clinical status of patients. Spearman correlation analysis was used to determine the correlation between the AChR‐Ab concentration and clinical score. The changes in the antibody concentration and clinical score are shown in MGFA‐antibody concentration–treatment plots. Results: Autoantibody detection tests were performed in 67 patients, and their clinical scores were recorded. Forty‐nine patients received immunosuppressive therapy, 17 patients received pyridostigmine only, and 1 patient under thymectomy without any medication. The AChR‐Ab concentration correlated with the MGFA Classification in 5 (29.4%) patients in the pyridostigmine‐only group and 15 (30.6%) patients in the immunosuppressive drug group. The changes in the MGFA Classification preceded the changes in the AChR‐Ab concentration in 4 (23.5%) patients treated with pyridostigmine and 10 (20.4%) patients on immunosuppressive drugs. In patients on oral non‐steroidal immunosuppressants, the AChR‐Ab concentration changed by more than 50%, whereas the MGFA Classification did not increase. The AChR‐Ab concentration decreased in 17/32 (53.1%) patients after thymectomy, and then increased, whereas the AChR‐Ab concentration increased in 15/32 (46.9%) patients and the MGFA Classification decreased in 27/32 (81.8%) patients after thymectomy. The AChR‐Ab concentration presented a slight correlation with the corresponding MGFA, QMG, and MG‐ADL in patients with thymoma. Discussion: In the Chinese AChR‐MG population, the Changes in the AChR‐Ab concentration in individuals with AChR‐MG did not consistently correlate with the severity of clinical symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
43. New Findings Reported from School of Foreign Studies Describe Advances in Psychology (Assessing perceptions of stigmatization by others for seeking help in China: psychometric characteristics and measurement invariance across gender and therapy...).
- Subjects
HELP-seeking behavior ,PSYCHOMETRICS ,FOREIGN study ,PSYCHOLOGY ,PSYCHOTHERAPY - Abstract
A recent study conducted in China examined the perceptions of stigmatization towards seeking help for mental health issues. The researchers developed and tested a scale called the Perceptions of Stigmatization by Others for Seeking Help (PSOSH) to measure this stigma. The study found that the PSOSH scale was reliable and valid for assessing social network stigmatization of professional help-seeking in Chinese community samples. The scale also showed invariance across gender and previous therapy experience, allowing for meaningful comparisons between different groups. This research highlights the importance of addressing stigma surrounding mental health in collectivist societies like China. [Extracted from the article]
- Published
- 2024
44. New Data from Peking University Illuminate Research in Prostate Cancer (Prevalence and risk evaluation of cardiovascular disease in the newly diagnosed prostate cancer population in China: A nationwide, multi-center, population-based...).
- Subjects
PROSTATE cancer ,POPULATION of China ,CARDIOVASCULAR diseases ,RISK assessment ,CARDIOVASCULAR diseases risk factors - Abstract
A recent report from Peking University in China discusses the prevalence and risk evaluation of cardiovascular disease (CVD) in newly diagnosed prostate cancer patients in China. The study found that CVD has become the leading cause of death in prostate cancer patients worldwide. The research also revealed that men with preexisting CVD have an increased risk of major adverse cardiovascular events when treated with androgen deprivation therapy (ADT). The study concluded that prostate cancer patients in China are often diagnosed at an advanced stage and have a heavy burden of CVD at the start of treatment. The awareness of cardiovascular protection in these patients was found to be insufficient. [Extracted from the article]
- Published
- 2024
45. Reports on Pneumonia Findings from Central South University Provide New Insights (Impact of Off-Hour Admission on In-Hospital Outcomes for Patients With Stroke Receiving Reperfusion Therapy in China).
- Subjects
REPERFUSION ,STROKE patients ,PNEUMONIA ,RESPIRATORY diseases ,RESPIRATORY infections - Abstract
A new report from Central South University discusses the impact of admission timing on in-hospital management and outcomes for patients with stroke receiving reperfusion therapy in China. The study found that patients admitted at nighttime were more likely to receive recommended therapies within the recommended time window. However, patients receiving endovascular treatment (EVT) admitted at night had an increased risk of pneumonia. The research highlights the importance of hospital structure and staffing in patient outcomes and provides new insights into the impact of off-hour admission on stroke treatment in China. [Extracted from the article]
- Published
- 2024
46. Researchers at Guizhou University of Traditional Chinese Medicine Have Reported New Data on Drug Research (Synthesis and Pharmacological Activity of Vinpocetine Derivatives).
- Subjects
CHINESE medicine ,RESEARCH personnel ,CHALCONE ,DRUGS - Abstract
Researchers at Guizhou University of Traditional Chinese Medicine have conducted a study on the synthesis and pharmacological activity of Vinpocetine derivatives. Vinpocetine and its derivatives have been used in the treatment of ischemic stroke as cerebrovascular vasodilators, and they have also shown potential for neuroprotection, anti-inflammatory purposes, anti-aging interventions, insomnia treatment, and antidepressant effects. The study aimed to address the limitations of Vinpocetine, such as hepatic first-pass effect, low bioavailability, and poor patient compliance with multiple dosing, by developing more potent derivatives. The research concluded that Vinpocetine and Vincamine are effective cerebrovascular vasodilators in the treatment of ischemic stroke. [Extracted from the article]
- Published
- 2024
47. Studies from Xi'an Jiaotong University Have Provided New Information about Drug Research (Combined Microfocused Ultrasound and Delicate Pulsed Light for Facial Rejuvenation: a Prospective, Randomized, and Split-face Study).
- Subjects
ULTRASONIC imaging ,REJUVENATION ,DRUGS ,UNIVERSITIES & colleges - Abstract
A study conducted by researchers at Xi'an Jiaotong University in Shaanxi, China, explored the efficacy and safety of combining microfocused ultrasound (MFU) with delicate pulsed light (DPL) for facial rejuvenation. Twenty-one patients with facial relaxation participated in the study, receiving MFU treatment on their entire face and DPL treatment on one side of their face. The results showed that the combined treatment led to a decrease in perioral wrinkles and nasolabial folds, as well as improvements in skin tone and elasticity. The researchers concluded that the combination of MFU and DPL is a safe and effective treatment for facial rejuvenation. [Extracted from the article]
- Published
- 2024
48. A Prospective, Multicenter, and Exploratory Study of Mitoxantrone Liposomes, Cytarabine and G-CSF Combined With Vineclavone in the Treatment ofRecurrent Adult AML and MDS-EB-2/Elder AML.
- Subjects
MITOXANTRONE ,CYTARABINE ,LIPOSOMES ,DIGESTIVE system diseases ,ACUTE myeloid leukemia - Published
- 2024
49. Research in the Area of Cancer Gene Therapy Reported from Ministry of Education (Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China).
- Subjects
CANCER genes ,GENE therapy ,CANCER treatment ,DRUG therapy ,CHRONIC diseases - Abstract
A recent study on cancer gene therapy in China has highlighted the significant global health concern of liver disease, particularly in China where it has distinctive characteristics. The study emphasizes the prevalence of liver diseases in China, including hepatitis B, metabolic non-alcoholic fatty liver disease, and hepatocellular carcinoma. Chinese hepatologists and researchers have made notable breakthroughs in the prevention, diagnosis, management, and treatment of liver diseases, with traditional Chinese medicines playing a significant role. The study also discusses the potential of extracellular vesicles, cell therapy, and gene therapy as innovative treatment options for liver diseases. [Extracted from the article]
- Published
- 2024
50. People's Hospital of Zhengzhou University Reports Findings in Sleep Disorders (Effects of transcranial direct current stimulation combined with tinnitus retraining therapy on sleep disorders in patients with chronic tinnitus).
- Subjects
TRANSCRANIAL direct current stimulation ,SLEEP disorders ,UNIVERSITY hospitals ,SENSORY stimulation ,TINNITUS ,NEUROLOGICAL disorders - Abstract
A study conducted at the People's Hospital of Zhengzhou University in Henan, China, investigated the effects of transcranial direct current stimulation (TDCS) combined with tinnitus retraining therapy (TRT) on sleep disorders in patients with chronic tinnitus. The study included 126 patients who were randomly divided into two groups: the electrical stimulation group and the combined group. The results showed that the combined group had better clinical efficacy, reduced tinnitus severity, improved sleep quality and psychological status, and enhanced quality of life compared to the electrical stimulation group. The study suggests that TDCS combined with TRT could be a valuable treatment option for chronic tinnitus. [Extracted from the article]
- Published
- 2024
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.